Stephen Chambers spent 22 years in some of the most innovative companies in life science as the director of gene expression and then as a co-founder of his own company. Today he runs SynbiCITE, the UK’s synthetic biology consortium of 56 industrial partners and 19 Academic institutions located at Imperial College in London. Stephen and … Continue reading »
life sciences
Why Lean May Save Your Life – The I-Corps @ NIH
Today the National Institutes of Health announced they are offering my Lean LaunchPad class (I-Corps @ NIH ) to commercialize Life Science. There may come a day that one of these teams makes a drug, diagnostic or medical device that saves your life. —- Over the last two and a half years the National Science Foundation I-Corps has taught … Continue reading »
Shake It Up, UC Berkeley Graduates!
Recently I had the privilege of delivering the commencement address to the graduating class in UC Berkeley’s program of Undergraduate and Interdisciplinary Studies. It was May 21, 2014 in the Greek Theater, and nearly 400 students received bachelor’s degrees in the fields of American Studies, Cognitive Science, Interdisciplinary Studies, Media Studies, and Religious Studies. Here’s … Continue reading »
Lessons Learned in Medical Devices
This post is part of our series on the National Science Foundation I-Corps Lean LaunchPad class in Life Science and Health Care at UCSF. Doctors, researchers and Principal Investigators in this class got out of the lab and hospital talked to 2,355 customers, tested 947 hypotheses and invalidated 423 of them. The class had 1,145 engagements with instructors … Continue reading »
Lessons learned in digital health
This post is part of our series on the National Science Foundation I-Corps Lean LaunchPad class in Life Science and Health Care at UCSF. Part 1: issues in the therapeutics drug discovery pipeline Part 2: medical devices and digital health Part 3: described what we’re going to do about it. Part 4: This Will Save us Years – Customer Discovery in Medical … Continue reading »
We’ve seen the future of translational medicine and it’s disruptive
A team of 110 researchers and clinicians, in therapeutics, diagnostics, devices and digital health in 25 teams at UCSF, has just shown us the future of translational medicine. It’s Lean, it’s fast, it works and it’s unlike anything else ever done. It’s going to get research from the lab to the bedside cheaper and faster. Welcome … Continue reading »
How Do You Want to Spend the Next 4 Years of Your Life?
As our Lean LaunchPad for Life Sciences class winds down, a good number of the 26 teams are trying to figure out whether they should go forward to turn their class project into a business. Given that we’ve been emphasizing Evidence-based entrepreneurship and the Investment Readiness Level, I guess I shouldn’t have been surprised when someone asked, “After … Continue reading »
Lean LaunchPad for Life Sciences – Revenue Streams
We’re teaching a Lean LaunchPad class for Life Sciences and Health Care (therapeutics, diagnostics, devices and digital health) at UCSF with a team of veteran venture capitalists. The class has talked to 2,056 customers to date. Part 1: issues in the therapeutics drug discovery pipeline Part 2: medical devices and digital health Part 3: described what we’re going to … Continue reading »
Well, they ‘should’ be our customers
When scientists and engineers who’ve been working in the lab for years try to commercialize their technology, they often get trapped by their own beliefs – including who the customers are, what features are important, pricing etc. One the key tenets of the Lean LaunchPad class is that every week each team gets out of … Continue reading »
This will save us years — Lean LaunchPad for Life Science
We’re deep into week 2 of teaching a Lean LaunchPad class for Life Sciences and Health Care (therapeutics, diagnostics, devices and digital health) this October at UCSF with a team of veteran venture capitalists. Part 1 of this post described the issues in the drug discovery. Part 2 covered medical devices and digital health. Part 3 described what we’re going … Continue reading »